Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol

The purpose of this study was to compare the efficacies of one initial intravitreal injection of aflibercept followed by a pro re nata (PRN; 1+PRN) regimen to those of three consecutive monthly injections followed by the PRN (3+PRN) regimen for diabetic macular edema (DME) with practical protocols....

Full description

Saved in:
Bibliographic Details
Main Authors: Yuko Hayashi, Tomoaki Tatsumi, Toshiyuki Oshitari, Tomomi Kaiho, Yoko Takatsuna, Miyuki Arai, Takayuki Baba, Shuichi Yamamoto
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2021/1374891
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395725105889280
author Yuko Hayashi
Tomoaki Tatsumi
Toshiyuki Oshitari
Tomomi Kaiho
Yoko Takatsuna
Miyuki Arai
Takayuki Baba
Shuichi Yamamoto
author_facet Yuko Hayashi
Tomoaki Tatsumi
Toshiyuki Oshitari
Tomomi Kaiho
Yoko Takatsuna
Miyuki Arai
Takayuki Baba
Shuichi Yamamoto
author_sort Yuko Hayashi
collection DOAJ
description The purpose of this study was to compare the efficacies of one initial intravitreal injection of aflibercept followed by a pro re nata (PRN; 1+PRN) regimen to those of three consecutive monthly injections followed by the PRN (3+PRN) regimen for diabetic macular edema (DME) with practical protocols. The medical records of 95 eyes of 71 cases that were diagnosed with DME and had received intravitreal aflibercept (IVA) injections were reviewed. Fifty-seven eyes had received IVA with the 1+PRN regimen, and 38 eyes had received IVA with the 3+PRN regimen. The best-corrected visual acuity (BCVA) and the central macular thickness (CMT) were measured at the baseline and at 1, 3, 6, and 12 months after the IVA. The mean number of injections of the 1+PRN group was 2.9±1.7, which was significantly fewer than that of the 3+PRN group at 4.6±1.4 (P<0.001). The change of the mean BCVA before and after the IVA at 12 months of the 3+PRN group was −0.14±0.17 logMAR units which was significantly better than that of the 1+PRN group of −0.045±0.25 logMAR units (P=0.02). The change of the CMT before and after the IVA at 6 months of the 3+PRN group was −141.3±152.4 μm which was significantly more than that of the 1+PRN group at −86.1±117.8 μm (P=0.013). Although the mean number of injections was more than that in the 1+PRN regimen, the 3+PRN regimen had better visual outcomes at 12 months. In a practical protocol, we recommend the 3+PRN regimen for patients with DME (IRB#3541).
format Article
id doaj-art-b6d9d76c89be472392ff63d65c6c3eaa
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-b6d9d76c89be472392ff63d65c6c3eaa2025-08-20T03:39:31ZengWileyJournal of Diabetes Research2314-67452314-67532021-01-01202110.1155/2021/13748911374891Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical ProtocolYuko Hayashi0Tomoaki Tatsumi1Toshiyuki Oshitari2Tomomi Kaiho3Yoko Takatsuna4Miyuki Arai5Takayuki Baba6Shuichi Yamamoto7Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanDepartment of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, JapanThe purpose of this study was to compare the efficacies of one initial intravitreal injection of aflibercept followed by a pro re nata (PRN; 1+PRN) regimen to those of three consecutive monthly injections followed by the PRN (3+PRN) regimen for diabetic macular edema (DME) with practical protocols. The medical records of 95 eyes of 71 cases that were diagnosed with DME and had received intravitreal aflibercept (IVA) injections were reviewed. Fifty-seven eyes had received IVA with the 1+PRN regimen, and 38 eyes had received IVA with the 3+PRN regimen. The best-corrected visual acuity (BCVA) and the central macular thickness (CMT) were measured at the baseline and at 1, 3, 6, and 12 months after the IVA. The mean number of injections of the 1+PRN group was 2.9±1.7, which was significantly fewer than that of the 3+PRN group at 4.6±1.4 (P<0.001). The change of the mean BCVA before and after the IVA at 12 months of the 3+PRN group was −0.14±0.17 logMAR units which was significantly better than that of the 1+PRN group of −0.045±0.25 logMAR units (P=0.02). The change of the CMT before and after the IVA at 6 months of the 3+PRN group was −141.3±152.4 μm which was significantly more than that of the 1+PRN group at −86.1±117.8 μm (P=0.013). Although the mean number of injections was more than that in the 1+PRN regimen, the 3+PRN regimen had better visual outcomes at 12 months. In a practical protocol, we recommend the 3+PRN regimen for patients with DME (IRB#3541).http://dx.doi.org/10.1155/2021/1374891
spellingShingle Yuko Hayashi
Tomoaki Tatsumi
Toshiyuki Oshitari
Tomomi Kaiho
Yoko Takatsuna
Miyuki Arai
Takayuki Baba
Shuichi Yamamoto
Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol
Journal of Diabetes Research
title Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol
title_full Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol
title_fullStr Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol
title_full_unstemmed Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol
title_short Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol
title_sort comparisons of one to three monthly injections of aflibercept for diabetic macular edema by practical protocol
url http://dx.doi.org/10.1155/2021/1374891
work_keys_str_mv AT yukohayashi comparisonsofonetothreemonthlyinjectionsofafliberceptfordiabeticmacularedemabypracticalprotocol
AT tomoakitatsumi comparisonsofonetothreemonthlyinjectionsofafliberceptfordiabeticmacularedemabypracticalprotocol
AT toshiyukioshitari comparisonsofonetothreemonthlyinjectionsofafliberceptfordiabeticmacularedemabypracticalprotocol
AT tomomikaiho comparisonsofonetothreemonthlyinjectionsofafliberceptfordiabeticmacularedemabypracticalprotocol
AT yokotakatsuna comparisonsofonetothreemonthlyinjectionsofafliberceptfordiabeticmacularedemabypracticalprotocol
AT miyukiarai comparisonsofonetothreemonthlyinjectionsofafliberceptfordiabeticmacularedemabypracticalprotocol
AT takayukibaba comparisonsofonetothreemonthlyinjectionsofafliberceptfordiabeticmacularedemabypracticalprotocol
AT shuichiyamamoto comparisonsofonetothreemonthlyinjectionsofafliberceptfordiabeticmacularedemabypracticalprotocol